Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M K Kägi

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Therapeutische Umschau. Revue Therapeutique|October 3, 1998
[Therapeutic management of neurodermatitis atopica]M K Kägi
Dermatology (Basel, Switzerland)|December 26, 2001
Leukotriene receptor antagonists--a novel therapeutic approach in atopic dermatitis?M K Kägi
Praxis|November 17, 1998
[Specific immunotherapy--past--present--future]M K Kägi
Annals of Allergy|August 1, 1993
Falafel burger anaphylaxis due to sesame seed allergyM K Kägi, B Wüthrich
Allergy|December 24, 1997
Anaphylactic reactions to ingested carmine (E120)B Wüthrich, M K Kägi, W Stücker
Schweizerische Medizinische Wochenschrift|March 16, 1996
[Visceral and neurological complications in Varicella infections of adults]E Bächli, M K Kägi, M Krause
Dermatology (Basel, Switzerland)|January 1, 1993
Disulfite-induced acute intermittent urticaria with vasculitisB Wüthrich, M K Kägi, J Hafner
Allergy|April 9, 1999
Soluble E-selectin correlates with disease activity in cyclosporin A-treated patients with atopic dermatitisM K Kägi, H Joller-Jemelka, B Wüthrich
Allergy|January 1, 1995
Levels of soluble ICAM-1 in atopic dermatitis. A new marker for monitoring the clinical activity?B Wüthrich, H Joller-Jemelka, M K Kägi
Dermatology (Basel, Switzerland)|January 1, 1992
Correlation of eosinophils, eosinophil cationic protein and soluble interleukin-2 receptor with the clinical activity of atopic dermatitisM K Kägi, H Joller-Jemelka, B Wüthrich
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Therapeutische Umschau. Revue Therapeutique|October 3, 1998
[Therapeutic management of neurodermatitis atopica]M K Kägi
Dermatology (Basel, Switzerland)|December 26, 2001
Leukotriene receptor antagonists--a novel therapeutic approach in atopic dermatitis?M K Kägi
Praxis|November 17, 1998
[Specific immunotherapy--past--present--future]M K Kägi
Annals of Allergy|August 1, 1993
Falafel burger anaphylaxis due to sesame seed allergyM K Kägi, B Wüthrich
Allergy|December 24, 1997
Anaphylactic reactions to ingested carmine (E120)B Wüthrich, M K Kägi, W Stücker
Schweizerische Medizinische Wochenschrift|March 16, 1996
[Visceral and neurological complications in Varicella infections of adults]E Bächli, M K Kägi, M Krause
Dermatology (Basel, Switzerland)|January 1, 1993
Disulfite-induced acute intermittent urticaria with vasculitisB Wüthrich, M K Kägi, J Hafner
Allergy|April 9, 1999
Soluble E-selectin correlates with disease activity in cyclosporin A-treated patients with atopic dermatitisM K Kägi, H Joller-Jemelka, B Wüthrich
Allergy|January 1, 1995
Levels of soluble ICAM-1 in atopic dermatitis. A new marker for monitoring the clinical activity?B Wüthrich, H Joller-Jemelka, M K Kägi
Dermatology (Basel, Switzerland)|January 1, 1992
Correlation of eosinophils, eosinophil cationic protein and soluble interleukin-2 receptor with the clinical activity of atopic dermatitisM K Kägi, H Joller-Jemelka, B Wüthrich
Pageof 2